Cognoptix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2001-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cognoptix.com
Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
Phase 1
- Conditions
- Mild Cognitive ImpairmentAlzheimer's Disease
- Interventions
- Device: Sapphire IIDrug: Aftobetin-HClRadiation: Positron Emission Tomography
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Cognoptix, Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT02928211
- Locations
- 🇺🇸
Neurology Research Institute, West Palm Beach, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath